As of 2025-04-22, the Fair Value of Vincerx Pharma Inc (VINC) is -28.75 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.28 USD, the upside of Vincerx Pharma Inc is -10,555.07%.
With the market price of 0.28 USD and our fair value calculation, Vincerx Pharma Inc (VINC) is not a good investment. Investing in VINC stocks now will result in a potential loss of 10,555.07%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -16.62 | -39.31 | -65.37 | -40.16 | -30.07 | -38.31 |
| YoY growth | -13,750.00% | -136.52% | -66.29% | 38.57% | 25.11% | -2,777.83% |
| Market Cap (mil) | 1.44 |
| P/E | |
| Forward P/E |
| EPS | -5.75 |
| Avg earnings growth rate | -2,777.83% |
| TTM earnings | -30.07 |